<rdema, so that a whole hemisphere may become cedematous, we have no idea what causes the sudden cedema which may occur spontaneously, just as it may do around a meningioma.
In cases of intracranial metastatic tumour all the complications~f .. al space-occupying mass within the skull miay bl seen, tonsillar herniation, hippocampal herniation, cingulate herniation, brain stem hnemorrhages and others. Two forms of involvement of the nervous system by carcinomata are relatively little known. These are carcinomatosis of the meninges or 'carcinomatous meningitis' (Fischer-Williams et a!. 1955) and the so-called 'carcinomatous encephalitis'. Clinically the fAost striking feature of 'carcinomatous meningitis' is headache which is extremely severe and is often associated with relatively insignificant signs. An early sign may be blindness from involvement of the optic nerves. In 'carcinomatous encephalitis' dementia may be the presenting symptom. Pathologically the brain usually looks perfectly normal macroscopically and it is not until it is studied histologically that the diagnosis can be made. In 'carcinomatous meningitis' a layer of tumour cells is seen lining the cerebrospinal pathways and the optic nerves are commonly ensheathed by these cells, a fact which presumably causes the visual disturbance although the exact mechanism by which the visual pathways are damaged is unknown. In 'carcinomatous encephalitis' the small vessels of the brain are cuffed by a layer of tumour cells, which presumably interfere with the passage of oxygen and metabolites to and from the cerebral tissues. In both these conditions it is possible in many cases to make a diagnosis by identifying tumour cells in the cerebrospinal fluid.
Finally, it must be remembered that various forms of degeneration of the nervous system may occur in association with carcinoma of various ... Fig 6 Transverse section of the spinal cord from a case of carcinoma of the lung. The patient had an almost complete sensory loss and there is complete demyelination ofthe posterior columns organs (especiallycarcinoma of the lung). The sensory neuropathy first described by Denny-Brown in 1948 in which severe loss of nerve cells in the posterior root ganglia leads to extensive sensory loss is probably less rare than is generally thought. In one case which I studied, the loss of cells in the ganglia was almost complete and the consequent degeneration in the posterior columns of the spinal cord ( Fig 6) was more severe than I had seen in any other condition, including tabes dorsalis. Cerebellar degeneration is also not uncommonly associated with carcinoma (Brain et al. 1951) . There is severe loss of Purkinje cells of the cerebellum, with degeneration of parts of the white matter. There is thought to be a myopathy associated with carcinoma (Brain & Henson 1958) , but this is not so clear cut pathologically as are the neuropathies and cerebellar lesions.
At present we have no idea of the real causes of these degenerations of the nervous system which are associated with carcinoma, but it seems most likely that they are due to some metabolic disturbance, presumably caused by the carcinoma.
Professor Sir Brian Windeyer (The Middlesex Hospital, London)
Metastases in the Central Nervous System: Treatment by Radiotherapy and Chemotherapy
The radiotherapist probably sees a high proportion of those patients who develop metastases in the central nervous system for whom any treatment is considered to be applicable. Many of them are already being treated for metastases in other parts of the body and the development of an intracranial or spinal metastasis may be a final stage in the evolution of generalized disease. Sometimes a metastasis in the central nervous system may be the first sign of recurrence after a period of months or years of well-being following an operation such as radical mastectomy or resection of cancer of the lung or apparently successful radiotherapy. This is illustrated by Fig 1 where the patient had had treatment for cancer of the cervix two years before. Sometimes such a metastasis may give the first presenting signs and symptoms of a previously undiscovered cancer and I have seen a number of such examples from Hodgkin's disease, from cancer of the thyroid, from cancer of the lung, and even from cancer of the breast.
The symptoms caused by the metastasis, the general condition of the patient, the number and site of other metastases, the site and histo-. logical nature of the primary lesion, and perhaps the previous treatment which the patient has undergone are all relevant factors in making an assessment as to what form of treat- Fig 1 Metas ment, if any, should be given to a particular patient.
The problems of dealing with a patient with intracranial metastases are so different from those posed by the development of a metastasis in the spine that I propose to deal with the subject in two separate sections.
Intracranial Metastases
The patient with intracranial metastases may be referred with a wide variety of symptoms, such as headache and vomiting caused by intracranial pressure, failing vision, nystagmus and loss of balance; or alterations in behaviour and in personality; or there may be various degrees of paralysis, or perhaps incipient and deepening coma.
In the majority of cases of intracranial metastasis, diagnosis appears only too certain, and is shortly proved by the evolution of the disease, but sometimes there is considerable uncertainty, and, in the absence of histological proof, the accuracy of diagnosis may be in question, particularly if the patient does well.
I have in the ward at present a woman who had a radical mastectomy for carcinoma of the breast in 1951. She had post-operative radiotherapy and remained well for six years. She then developed occipital headache with attacks of vomiting and nausea. The EEG showed a mild abnormality and after considerable investigation it was thought that she probably had a posterior fossa metastasis. She was treated by the administration of testosterone and, as she became rather worse, was treated by X-rays to the posterior fossa. At that time, March 1958, my neurological colleague said the patient had a pos-terior fossa lesion affecting the cerebellum in the midline and on the right and also the brahn stein which must be due ,tases in base of skull from carcinoma of the cervix uteri years previously to secondary deposits. She was much better after irradiation and remained well until July 1961 when she developed further symptoms. It was thought that she had a new metastasis in the midbrain. Testosterone was started again and further irradiation given to the mid-brain region. Her condition has remained practically stationary since then, with some ataxia, but she leads a fairly normal life and has no sign of recurrence of cancer of the breast. We have wondered if the diagnosis was correct and whether we should have treated her head by irradiation but she has now been admitted with dysphagia due to external pressure on the cesophagus. She also had a skin nodule which was found to be recurrent carcinoma.
The decision as towhether anytreatment should be given is often a difficult one, and it may be worth while to try to determine what advantages can be gained by treatment, and what the disadvantages are, including the ordeal which may have to be undergone.
It has become axiomatic from our present knowledge and our present methods of treatment of cancer that the treatment of any blood-borne metastases cannot result in cure and that the best result that can be obtained is palliation of symptoms for a varying period of time until further metastases develop.
Such palliation, however, may be ofinestimable value. It may give some years of additional happy and comfortable life. It may give relief of painful and distressing symptoms even though the prolongation of life may be slight. It is, however, important to realizethat treatment whichis givenwith palliative intent should indeed palliate and should not be given for the sake of giving treatment or if it is likely to make the patient's eventual condition more miserable and unhappy.
In the case of intracranial metastases such considerations frequently arise. If the amount of brain destruction by the metastasis is such that it is obvious that the patient, even though he may survive after treatment, will be miserable and severely handicapped, I consider that treatment should not be undertaken unless it is the only way to relieve pain and distress.
If there are other generalized metastases which 'have caused deterioration in the patient's condition, or pain or other disability, the development of an intracranial metastasis may be one way in which he may obtain a happy release and the institution of treatment to it might be unwarranted sand unkind.
On the other hand, there is a great deal to be gained by the treatment of patients who are in otherwise good general condition, who do not have other obvious metastases, and particularly if it is known that the type of growth is likely to respond without excessive dosage.
The type of response can perhaps be most conveniently described by reference to some illustrative examples of patients who have recently been under treatment.
A man aged 52 had an ulcerated malignant melanoma remoyed from the anterior abdominal wall in March 1963. He was thought to have developed metastatic deposits in the cerebral hemispheres in July 1963 and was given melphalan. His condition deteriorated with development of papillcedema and left-sided homonymous hemianopia. The melphalan had to be stopped owing to depression of his white cell count. He was given X-ray therapy in September and October to a dose of 4,000 rads to his cerebrum; his eyesight recovered but he developed epileptiform convulsions. When last seen, on April 1, 1964, he was well and his fits have been controlled by phenobarbitone and phenytoin. He undoubtedly has metastases which will develop again in the course of time but he has been relieved for more than six months.
Another patient had resection of carcinoma of the lung early in 1960, and in October of that year he had signs of intracranial metastasis. He was treated by radiotherapy with a cobalt unit with complete recovery, having received 3,000 rads. In April 1961 he had signs of further cerebral metastases and received further treatment with a cobalt unit with a dose of 4,600 rads. Again the recovery was complete and dramatic. In the last few months there has been a deterioration in his condition, particularly his intellect and memory, and some weakness in his legs. It is thought that this deterioration is now most probably due to the late effects of the considerable radiation that he has received rather than to a further recurrence.
Spinal Cord Involvement
Metastases involving the spine may present on account of pain or of sensory or motor disturbances of varying degrees of severity. The, onset and progress may be slow and insidious, or symptoms may develop with great rapidity. There may be X-ray evidence of vertebral involvement and sometimes the first sign is the sudden development of complete paraplegia associated with collapse of a vertebra. It is rarely the bony deformity which is important but the soft tissue mass associated with it. The metastasis may be extradural with no sign of vertebral involvement and it must be remembered that in the upper dorsal region X-ray evidence of early bone invasion may be difficult or impossible to see without tomography or other special investigations.
Here too, the spinal metastasis may be the first manifestion of disease, as illustrated by Fig 2 from a patient admitted with rapidly developing paraplegia which was the first sign or symptom of Hodgkin's disease. We have had several patients with carcinoma of the thyroid who came initially with symptoms from a vertebral deposit. Another patient (Figs 3 & 4) complained that she hurt her back when she fell off her bicycle. She was one of a small series who was treated with marked success, lasting over a number of years, by radioactive iodine for a well-differentiated adenocarcinoma of the thyroid. The spinal metastasis may be associated with other widespread skeletal and soft tissue deposits. This is not uncommon in cases of advanced cancer of the breast or in Hodgkin's disease. Fig 5 illustrates the case of a patient who had been under treatment for several years for many manifestations of Hodgkin's disease before she developed pain in her back and weakness of her legs. She was found to have a mixture of osteosclerotic and osteolytic deposits in the same vertebra.
In the spine also there have been some instances where the diagnosis has given rise to difficulty. In the absence 'of X-ray evidence of bone involvement and with a history of a previously treated carcinoma, a localized thrombosis has been mistaken for a metastasis.
Two patients whom I have seen in the last year have received radiotherapy elsewhere for carcinoma of the bronchus and carcinoma of the cesophagus. The beam of radiation had obviously passed through the thoracic spine and there has been subsequent development of a local lesion at this level. It was thought that this was most likely due to radiation damage but metastases could not be excluded at the time.
Such radiation damage usually takes several years to develop. It has been seen when treatment has been given with palliative intent to the primary lesion, in the chest and an unexpectedly good and long-lasting result has been achieved. The possibility that this may occur should make the careful planning even of palliative treatments a matter of great importance.
In the case of spinal metastases, I believe that treatment designed to relieve pressure should be carried out as soon as possible in almost every-instance a-nd that really the only contraindication to treatment, except for widespread and terminal disease, is long-standing paraplegia which has no chance of recovery.
When paresis develops rapidly there is need for urgent treatment to relieve pressure on the cord and in most instances, except when one is dealing with an exceptionally radiosensitive tumour, I believe it is advisable to carry out a laminectomy and obtain immediate decompression, rather than to give radiotherapy which may not be sufficiently rapid or sufficiently certain in its effect. The laminectomy is immediately followed by radiotherapy.
For both intracranial and spinal metastases I consider that radiotherapy is most generally useful and that chemotherapy should be employed only when it is a question of treating widespread deposits from a condition of known radiosensitivity. Even then I would prefer radiotherapy to deal with a localized lesion causing definite symptoms. The beam of radiotherapy can be directed with considerable accuracy and it is possible to deliver'adequate dosage to the required site without over-irradiation of other tissues.
Much work has been done on developing a technique for treatment of intracranial tumours by intra-arterial perfusion. I have not been impressed with what I have seen. There are several instances where rapid disintegration of a tumour treated in this way has caused death by hmemorrhage. Perhaps it is a question of perfection of technique and dosage and the same type of accident has been seen following radiotherapy. I feel, however, that radiotherapy is more easily controlled to give any required dosage to a selected volume of tissue, and the real difficulty is to determine exactly the site and extent of the lesion to be treated.
In the treatment of metastases from cancer of the breast hormone administration may be the most important and most efficacious method. I have already mentioned patients treated by testosterone administration. In elderly patients some ten years beyond the menopause aestrogens may have the same effect. A woman aged 75 ( Figs 6 & 7A, B) who came with a neglected, ulcerated cancer of the breast with metastases in the spine and weakness of the legs was transferred to a home for terminal care and given stilbeestrol. She came to see me a year later with no symptoms and the breast lesion had disappeared.
Apart from the administration of androgens and aestrogens, hormonal surgery by ablation of pituitary function, or bilateral adrenalectomy may be indicated. The exact indications or the preference for the one procedure or the other are still the subject of discussion.
There are different patterns of response for different types of cancer and in general the metastases 'respond-in the same way as the primary lesions. There are, however, marked differences in the response of individual tumours to the general pattern. In some instances, a tumour of a generally responsive type does not respond despite heavy dosage. In others, apparently radioresistant lesions can be treated with success. For example, there are undoubtedly some cases of malignant melanoma which respond to radiotherapy and I have already quoted one. I believe that, in the case of intracranial and spinal metastases, the type of malignant disease should not be a determining factor in giving or withholding treatment. The ordeal which the patient has to undergo in receiving radiotherapy is not a severe one. It is not a painful or unduly disturbing treatment, and in many cases the most upsetting feature is the loss of hair which occurs. In many instances radiotherapy is the only proce--dure which has a chance of giving palliation. There are, of course, some conditions from which one would expect a better response than from others. I have not observed any worth-while response when there has been collapse of a vertebra and pressure on the cord in multiple myelomatosis (Fig 8) . On the other hand, cases of reticulum cell sarcoma of bone, even though more than one site may be involved, frequently heal and remain healed for prolonged periods of time with complete alleviation of symptoms. This is illustrated in Fig 9 A, B from a patient who presented in 1950 with reticulum cell sarcoma involving the humerus and the dorsal spine. She has since married and over the years has developed other metastases in the pelvis and retroperitoneal nodes. Last year she had further radiotherapy to a space-occupying lesion in the frontoparietal region and when seen two weeks ago she was cheerful and able to concentrate and run her home without difficulty.
It is difficult to discuss the treatment of metastases with any statistical evaluation. It is a very personal assessment of what is worth while for an individual patient.
Mr J E A O'Connell (St Bartholomew's Hospital, London)
The Place of Surgery in Intracranial Metastatic Malignant Disease Primary malignant tumours present the surgeon with considerable problems; when the disease is secondary these problems are enormously increased and frequently insuperable.
A number of reviews of large series of cases of metastatic malignant tumours of the brain have appeared. When these are based on a neurological surgeon's experience the incidence among brain tumours has been 3-5 % (Stortebecker 1954), 1963) . In reviews by pathologists of autopsy brain tumour material the incidence is greater: 13-5 % (Globus & Meltzer 1942), 17 % (Courville 1937), and in the case of some German workers 37 %.
In both surgical and autopsy series the sites of the primary carcinomata correspond, with slight variations, although the number of cases in which the primary neoplasm remained undiscovered is naturally greater in the surgical series, reaching as high a figure as 32% (Stortebecker 1954) . In most series the common primary has been the lung (60%), followed by breast, gastro-intestinal tract and kidney. In the autopsy series it has been noted that a primary bronchial carcinoma or pulmonary metastases were present in 80% of cases (Globus & Meltzer 1942 , Tom 1956 . It is noteworthy too that in autopsy series (Globus & Meltzer 1942 , Stortebecker 1954 ) the brain metastases were multiple or diffuse in two-thirds of the series examined. Flavell (1949) investigated the records of 85 cases of carcinoma of the bronchus with cerebral metastases coming to autopsy at the London Hospital. In 31% the cerebral deposit was solitary but there were metastases elsewhere in many of them; in 9 4% the metastasis in the brain was the only one found apart from involvement of the hilar nodes. In view of the frequently generalized nature of the disease in the brain and elsewhere in the body it is obvious that surgery can have little to offer most patients. Thus Livingstone et al. (1948) found that of 51 surgically treated cases 18 died in less than one month, 17 more in less than six months and of 16 surviving for more than six months only 8 or 12 % of the series survived for two years. Stortebecker (1954) found that the average period of survival after operation in 125 cases was ten and a half months; there was often a temporary improvement in general health and a few patients returned to work for a short period (15 %). Richards & McKissock (1963) analyse the survival in 342 of their series of 389 cases; of the 164 treated cases 74 % survived for five months or less and for 178 untreated cases this figure was 90%.
Surgical reviews of metastatic brain tumours inevitably provide an incomplete picture. In the first place the cases are selected before as well as after arrival in a neurosurgical department; many patients in whom the diagnosis of metastatic brain tumour is clear will not be referred for treatment: moreover selection will be exercised in ,so far as the cases coming under neurosurgical care are concerned. Secondly, surgical reports are as a whole concerned with discrete tumours whereas metastatic malignant disease may take other forms. Thirdly, most reports consider only metastases to the brain through the blood stream whereas the cerebrospinal fluid circulation plays a part in the distribution of metastases. It seems possible then that a different though surgical approach would be of interest and therefore the anatomical varieties of metastatic malignant disease will be reviewed from the pathological, clinical and diagnostic viewpoints.
Dural Metastasis
In several of the recorded series of metastatic intracranial neoplasms diffuse tumour formation on the dura mater is mentioned. The clinical picture resulting from such deposits may be a difficult one to interpret as the following account demonstrates.
